Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Ally Financial Inc (ALLY) Price & Performance

Adaptive Biotechnologies CorpTrade
Ally Financial IncTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Ally Financial Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Ally Financial Inc trades at $44.15 (market cap $13.37B). The key difference: Ally Financial Inc is far larger — about 3.3× Adaptive Biotechnologies Corp's market cap, and Ally Financial Inc pays a 2.73% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTALLY
Market Cap
$4.04B$13.37B
Sector
HealthFinancials
52-Week High
$25.45$47.25
52-Week Low
$12.30$35.96
Enterprise Value
$4.10B
Dividend Yield
2.73%

Returns comparison

Trailing returns across standard periods

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Ally Financial Inc

Ally Financial Inc is a diversified financial services firm that services automotive dealers and their retail customers. The company operates as a financial holding company and a bank holding company. Its banking subsidiary, Ally Bank, caters to the direct banking market through Internet, mobile, and mail. The company reports four business segments including Automotive Finance operations, Insurance operations, Mortgage Finance operations and Corporate Finance operations.

Read more on ALLY